Enasidenib(Idhifa) Side Effects

This section lists the most common and clinically significant adverse reactions associated with IDHIFA.

Adverse Reactions

The most frequently reported adverse reactions (occurring in ≥20% of patients) include nausea, vomiting, diarrhea, elevated blood bilirubin, and decreased appetite. A serious and potentially fatal side effect is differentiation syndrome, which requires immediate management with corticosteroids. Other significant adverse reactions can include noninfectious leukocytosis and tumor lysis syndrome. Laboratory abnormalities often include increased total bilirubin and decreased calcium levels.

Enasidenib(Idhifa)
Treatment of relapsed or refractory acute myeloid leukemia (AML) in adult patients with a confirmed IDH2 mutation.
RELATED ARTICLES
What Are the Side Effects of Enasidenib?

Enasidenib is an isocitrate dehydrogenase-2 (IDH2) inhibitor used to treat adult patients with relapsed or...

Friday, October 17th, 2025, 13:34
What Are the Side Effects of Enasidenib?

Enasidenib is an isocitrate dehydrogenase-2 (IDH2) inhibitor indicated for the treatment of adult patients with...

Wednesday, September 24th, 2025, 14:46
/ 1
2 in total
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
Mailbox:Info@Lucius.La
Welcome To Consult
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved